US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Latest News about EPIC/Skin

Recent news which mentions EPIC/Skin

OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer
Tags Germany Rhenium/SCT EPIC/Skin
From PRLog
Fully recruited EPIC-Skin international study for the treatment of Non-Melanoma Skin Cancer
Tickers EPIC
Tags Basal Cell Carcinoma Epic Clinical Study
From PRLog
South African skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
Tags Non/melanoma skin cancer Squamous Cell Carcinoma Medical
From PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
Tags Research Non/invasive OncoBeta GmbH
From PRLog
German skin cancer patients join the EPIC-Skin study
Tags OncoBeta GmbH Research Non/invasive
From PRLog
Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
Tags Beauty OncoBeta GmbH Research
From PRLog
Austrian skin cancer patients take part in EPIC-Skin clinical study
Tags Basal Cell Carcinoma Rhenium/188 NMSC therapy
From PRLog
EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta's Rhenium-SCT
Tags South Africa Munich Painless
From PRLog